benazepril hydrochloride and hydrochlorothiazide (62559-414)

Drug Facts

Product Profile

Brand Name benazepril hydrochloride and hydrochlorothiazide

Generic Name benazepril hydrochloride and hydrochlorothiazide

Labeler ani pharmaceuticals, inc.

Dosage Form TABLET

Routes

ORAL

Active Ingredients

benazepril hydrochloride 5 mg/1, hydrochlorothiazide 6.25 mg/1

Manufacturer

ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 62559-414

Product ID 62559-414_052493c7-89a3-452e-8140-04dd95f0d9e2

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA076342

Listing Expiration 2026-12-31

Marketing Start 2022-11-07

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62559414

Hyphenated Format 62559-414

Supplemental Identifiers

RxCUI

898362 898367 898372 898378

UPC

0362559415019 0362559416016 0362559414012 0362559417013

UNII

0J48LPH2TH N1SN99T69T

NUI

N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Generic Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Application Number ANDA076342 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

5 mg/1
6.25 mg/1

source: ndc

Packaging

100 TABLET in 1 BOTTLE (62559-414-01)

source: ndc

Packages (1)

62559-414-01 100 TABLET in 1 BOTTLE (62559-414-01)

Ingredients (2)

benazepril hydrochloride (5 mg/1) hydrochlorothiazide (6.25 mg/1)

Linked Drug Pages (1)

Benazepril Hydrochloride and Hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "052493c7-89a3-452e-8140-04dd95f0d9e2", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0362559415019", "0362559416016", "0362559414012", "0362559417013"], "unii": ["0J48LPH2TH", "N1SN99T69T"], "rxcui": ["898362", "898367", "898372", "898378"], "spl_set_id": ["e6527adf-8c74-4d81-9199-d56a7fca895e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (62559-414-01)", "package_ndc": "62559-414-01", "marketing_start_date": "20221107"}], "brand_name": "Benazepril Hydrochloride and Hydrochlorothiazide", "product_id": "62559-414_052493c7-89a3-452e-8140-04dd95f0d9e2", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "62559-414", "generic_name": "Benazepril Hydrochloride and Hydrochlorothiazide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Benazepril Hydrochloride and Hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "6.25 mg/1"}], "application_number": "ANDA076342", "marketing_category": "ANDA", "marketing_start_date": "20221107", "listing_expiration_date": "20261231"}